Description
Fosbait 500 Chewable Tablet is a medication primarily used to manage hyperphosphatemia, a condition characterized by abnormally high levels of phosphate in the blood. This is often seen in patients with chronic kidney disease (CKD) who are undergoing dialysis. The active ingredient in Fosbait 500 is Sevelamer Carbonate, a non-calcium, non-aluminum, cross-linked polymer that binds to dietary phosphate in the gastrointestinal tract. By binding to phosphate, it prevents its absorption into the bloodstream, thereby lowering serum phosphate levels. This helps to prevent complications associated with hyperphosphatemia, such as renal osteodystrophy and cardiovascular calcification. Fosbait 500 is designed to be chewed, making it easier for patients to take, especially those who have difficulty swallowing pills. It is typically prescribed as an adjunct to diet and other treatments for hyperphosphatemia. The dosage should be determined by a healthcare professional based on the patient’s serum phosphate levels and dietary intake. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, constipation, and abdominal pain. It is important to store Fosbait 500 Chewable Tablets at room temperature, away from moisture and direct heat, and out of reach of children.
